Around the globe there is high interest in the use of cannabidiol, for the treatment of people with epilepsy, especially children who have treatment-resistant forms of the disorder. Three studies presented at the American Epilepsy Society's 69th Annual Meeting in Philadelphia highlight emerging efficacy and safety data of Epidiolex, a pharmaceutical liquid formulation of cannabidiol. A fourth study highlights possible interactions of CBD with existing anti-epileptic drugs in animal models of seizures.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1NesfAY
No comments:
Post a Comment